CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
about
Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromesMutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinomaHistone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5.The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma.
P2860
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
@en
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
@nl
type
label
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
@en
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
@nl
prefLabel
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
@en
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1111/LIV.12503
P577
2014-03-15T00:00:00Z